Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.

@article{Murashige2005AllogeneicHS,
  title={Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.},
  author={Naoko Murashige and Masahiro Kami and Yukiko Kishi and Sung-won Kim and M Takeuchi and Kosei Matsue and Yoshinobu Kanda and Makoto Hirokawa and Yoshinari Kawabata and T Matsumura and Eiji Kusumi and Noriyuki Hirabayashi and Koji Nagafuji and Ritsuro Suzuki and Kengo Takeuchi and Kazuo Oshimi},
  journal={British journal of haematology},
  year={2005},
  volume={130 4},
  pages={561-7}
}
The efficacy of allogeneic haematopoietic stem-cell transplantation (allo-HSCT) for natural killer (NK)-cell neoplasms is unknown. We investigated the results of allo-HSCT for NK-cell neoplasms between 1990 and 2003 through questionnaires. After reclassification by a haematopathologist, of 345 patients who underwent allo-HSCT for malignant lymphoma, 28 had NK-cell neoplasms (World Health Organization classification): extranodal NK/T-cell lymphoma (n=22), blastic NK-cell lymphoma (n=3), and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 47 extracted citations

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Journal of hematology & oncology • 2018
View 1 Excerpt

NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.

Journal of the National Comprehensive Cancer Network : JNCCN • 2018

Similar Papers

Loading similar papers…